Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-08-29

Clinical Trial Update: Hair Testing to Assess Consumption of Illicit Psychotropic Agents and Alcohol by Patients Treated With High-dose Buprenorphine and Methadone. Search for a Pharmacogenetic Contribution to Low Efficacy of Substitution Medications [NA]

View source ↗

Summary

This clinical trial update describes hair testing to monitor use of illicit psychotropic agents and alcohol in patients treated with high-dose buprenorphine and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methadone (methadone)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Substance Abuse | NA | Status: UNKNOWN